Home › Graves Disease › Massachusetts
Graves Disease clinical trials in Massachusetts
3 studies for Graves Disease are looking for participants at sites in Massachusetts.
NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease
- Site # 1107, Boston
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Oct 29, 2026 · NCT07305818Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)
- Ophthalmic Consultants of Boston, Inc, East Weymouth
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 20, 2026 · NCT07753603A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Site Number - 1026, Boston
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 25, 2026 · NCT06727604From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.